{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:36:53Z","timestamp":1776184613052,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1097\/pas.0b013e31817150e3","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T16:00:51Z","timestamp":1236268851000},"page":"1130-1137","source":"Crossref","is-referenced-by-count":114,"title":["\u03b1-CTLA-4 mAb-associated Panenteritis"],"prefix":"10.1097","volume":"32","author":[{"given":"Darryl A.","family":"Oble","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Mino-Kenudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Stephen","family":"Hodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania M.","family":"Seliem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Dranoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Mihm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hasserjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.","family":"Lauwers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210131","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1200\/JCO.2005.06.205","article-title":"Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4","volume":"23","author":"Attia","year":"2005","journal-title":"J Clin Oncol"},{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1172\/JCI25112","article-title":"Defective regulatory and effector T cell functions in patients with FOXP3 mutations","volume":"116","author":"Bacchetta","year":"2006","journal-title":"J Clin Invest"},{"key":"R3-3-20210131","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1200\/JCO.2005.04.5716","article-title":"Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte\u2013associated antigen 4","volume":"24","author":"Beck","year":"2006","journal-title":"J Clin Oncol"},{"key":"R4-3-20210131","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00008480-200112000-00007","article-title":"IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena","volume":"13","author":"Bennett","year":"2001","journal-title":"Curr Opin Pediatr"},{"key":"R5-3-20210131","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1200\/JCO.2001.19.3.756","article-title":"Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography","volume":"19","author":"Cartoni","year":"2001","journal-title":"J Clin Oncol"},{"key":"R6-3-20210131","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.immunol.19.1.565","article-title":"CTLA-4\u2013mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy","volume":"19","author":"Chambers","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"R7-3-20210131","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1523-5394.2001.009002071.x","article-title":"Monoclonal antibody therapy for lymphoma","volume":"9","author":"Dillman","year":"2001","journal-title":"Cancer Practice"},{"key":"R8-3-20210131","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ni0702-611","article-title":"CTLA-4: new insights into its biological function and use in tumor immunotherapy","volume":"3","author":"Egen","year":"2002","journal-title":"Nat Immunol"},{"key":"R9-3-20210131","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00002281-200307000-00010","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis","volume":"15","author":"Gambineri","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"R10-3-20210131","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1517\/13543784.16.4.477","article-title":"Emerging monoclonal antibody therapies for malignant gliomas","volume":"16","author":"Gerber","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"R11-3-20210131","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s00520-006-0040-y","article-title":"Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies","volume":"14","author":"Gibson","year":"2006","journal-title":"Support Care Cancer"},{"key":"R12-3-20210131","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0167-5699(00)01669-8","article-title":"Clinical trials of antibody therapy","volume":"21","author":"Glennie","year":"2000","journal-title":"Immunol Today"},{"key":"R13-3-20210131","first-page":"S72","article-title":"Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines","volume":"24","author":"Griffiths","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"R14-3-20210131","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1073\/pnas.0830997100","article-title":"Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients","volume":"100","author":"Hodi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-3-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.180.1.1","article-title":"Cancer antigens: immune recognition of self and altered self","volume":"180","author":"Houghton","year":"1994","journal-title":"J Exp Med"},{"key":"R16-3-20210131","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2165\/00003495-200666090-00002","article-title":"Novel treatment options for inflammatory bowel disease: targeting alpha 4 integrin","volume":"66","author":"Lanzarotto","year":"2006","journal-title":"Drugs"},{"key":"R17-3-20210131","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.immunol.14.1.233","article-title":"CD28\/B7 system of T cell costimulation","volume":"14","author":"Lenschow","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"R18-3-20210131","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.4049\/jimmunol.175.11.7746","article-title":"Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade","volume":"175","author":"Maker","year":"2005","journal-title":"J Immunol"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1245\/ASO.2005.03.536","article-title":"Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I\/II study","volume":"12","author":"Maker","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"R21-3-20210131","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.humpath.2007.01.014","article-title":"Pathological effects of drugs on the gastrointestinal tract: a review","volume":"38","author":"Parfitt","year":"2007","journal-title":"Hum Pathol"},{"key":"R22-3-20210131","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1073\/pnas.1533209100","article-title":"Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma","volume":"100","author":"Phan","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.4049\/jimmunol.177.7.4376","article-title":"Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo","volume":"177","author":"Read","year":"2006","journal-title":"J Immunol"},{"key":"R24-3-20210131","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/cncr.21854","article-title":"Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma","volume":"106","author":"Reuben","year":"2006","journal-title":"Cancer"},{"key":"R25-3-20210131","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1200\/JCO.2005.01.109","article-title":"Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206","volume":"23","author":"Ribas","year":"2005","journal-title":"J Clin Oncol"},{"key":"R26-3-20210131","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1200\/JCO.2005.01.128","article-title":"Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma","volume":"23","author":"Sanderson","year":"2005","journal-title":"J Clin Oncol"},{"key":"R27-3-20210131","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1517\/14712598.7.4.487","article-title":"Adjuvant treatment of breast cancer: impact of monoclonal antibody therapy directed against the HER2 receptor","volume":"7","author":"Simonds","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/01.cji.0000211334.06762.89","article-title":"Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA-4 monoclonal antibody","volume":"30","author":"Smith","year":"2007","journal-title":"J Immunother"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1200\/JCO.2003.07.005","article-title":"Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma","volume":"21","author":"Soiffer","year":"2003","journal-title":"J Clin Oncol"},{"key":"R30-3-20210131","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.192.2.303","article-title":"Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4","volume":"192","author":"Takahashi","year":"2000","journal-title":"J Exp Med"},{"key":"R31-3-20210131","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev.med.54.101601.152442","article-title":"Monoclonal antibody therapy for cancer","volume":"43","author":"von Mehren","year":"2003","journal-title":"Annu Rev Med"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000478-200808000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T03:03:16Z","timestamp":1618023796000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-200808000-00003"}},"subtitle":["A Histologic and Immunohistochemical Analysis"],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e31817150e3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1116114.572095","asserted-by":"object"}]},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}